Want to see THC full AI Analyst Report?
THC Stock Chart & Stats
$196.64
$1.59(1.23%)
At close: 4:00 PM EST
$196.64
$1.59(1.23%)
Day’s Range― - ―
52-Week Range$146.60 - $247.21
Previous CloseN/A
Volume281.04K
Average Volume (3M)1.27M
Market Cap
$16.79B
Enterprise Value$30.81K
Total Cash (Recent Filing)$2.97B
Total Debt (Recent Filing)$13.21B
Price to Earnings (P/E)10.0
Beta0.99
Next Earnings
Jul 24, 2026EPS Estimate
4.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)19.39
Shares Outstanding86,137,000
10 Day Avg. Volume1,251,825
30 Day Avg. Volume1,268,326
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)4.25
Price to Sales (P/S)0.84
P/FCF Ratio7.08
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$241.29Price Target Upside22.70% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15
EPS Forecast (FY)17.94
Revenue Forecast (FY)$21.97B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow & LiquiditySustained high operating and free cash flow, plus nearly $3.0B cash on hand, creates durable financial flexibility. This supports organic investment, the $250M USPI M&A plan, continued buybacks and selective debt reduction, cushioning Tenet against reimbursement cycles and funding strategic growth.
High‑margin Ambulatory Platform (USPI)USPI's outsized margins and same‑facility revenue growth reflect a durable secular shift to outpatient care. Active ASC M&A and de novos expand a higher‑margin, asset‑light business that diversifies revenue away from lower‑margin inpatient services and sustainably improves consolidated profitability.
Meaningful Deleveraging And Improved Capital StructureMaterial reduction in leverage versus recent peaks lowers refinancing and liquidity risk and increases strategic optionality. A stronger balance sheet supports continued buybacks, targeted M&A and potential debt retirement, making the business more resilient to cyclical or reimbursement shocks.
Bears Say
Exchange Enrollment & Payor Mix PressureDeclining exchange enrollments reduce higher‑reimbursement commercial‑style volumes and create persistent payor‑mix pressure. A multi‑quarter reduction in exchange volumes meaningfully lowers revenue per admission and raises uncertainty around sustainable top‑line growth and margin recovery.
Material Respiratory Volume DeclineA large, sustained drop in respiratory cases materially reduces inpatient throughput and revenue mix. If post‑pandemic normalization or weaker seasonal respiratory demand persists for quarters, hospital segment volumes and associated margins can remain depressed, limiting near‑term earnings durability.
Elevated Payer Disputes/denials And Regulatory UncertaintyPersistently elevated denials increase collections risk, raise working‑capital needs and drive administrative costs. Coupled with pending CMS outpatient rule and enrollment uncertainty, this structural reimbursement and regulatory risk can depress realized revenue and cash conversion over multiple quarters.
THC FAQ
What was Tenet Healthcare Corp.’s price range in the past 12 months?
Tenet Healthcare Corp. lowest stock price was $146.60 and its highest was $247.21 in the past 12 months.
What is Tenet Healthcare Corp.’s market cap?
Tenet Healthcare Corp.’s market cap is $16.79B.
When is Tenet Healthcare Corp.’s upcoming earnings report date?
Tenet Healthcare Corp.’s upcoming earnings report date is Jul 24, 2026 which is in 3 days.
How were Tenet Healthcare Corp.’s earnings last quarter?
Tenet Healthcare Corp. released its earnings results on Apr 30, 2026. The company reported $4.82 earnings per share for the quarter, beating the consensus estimate of $4.165 by $0.655.
Is Tenet Healthcare Corp. overvalued?
According to Wall Street analysts Tenet Healthcare Corp.’s price is currently Undervalued.
Does Tenet Healthcare Corp. pay dividends?
Tenet Healthcare Corp. does not currently pay dividends.
What is Tenet Healthcare Corp.’s EPS estimate?
Tenet Healthcare Corp.’s EPS estimate is 4.26.
How many shares outstanding does Tenet Healthcare Corp. have?
Tenet Healthcare Corp. has 86,137,000 shares outstanding.
What happened to Tenet Healthcare Corp.’s price movement after its last earnings report?
Tenet Healthcare Corp. reported an EPS of $4.82 in its last earnings report, beating expectations of $4.165. Following the earnings report the stock price went down -1.655%.
Which hedge fund is a major shareholder of Tenet Healthcare Corp.?
Currently, no hedge funds are holding shares in THC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Tenet Healthcare Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$241.29 (22.70% Upside)
$241.29 (22.70% Upside)
Blogger Sentiment
Bullish
THC Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 207.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.3%
Last 30 Days ▼ 5.4%
Last 30 Days ▼ 5.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
11.28%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
6.72%
Trailing 12-Months
Company Description
Tenet Healthcare Corp.
Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care facilities, Tenet delivers a full spectrum of essential services. These include core hospital functions such as operating and recovery suites, radiology and respiratory therapy, clinical laboratories, and on-site pharmacies. The organization also provides high-acuity patient care through intensive, critical, and coronary care units. Specialized medical services cover areas like cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics, alongside various outpatient treatments, including physical therapy. Advanced surgical capabilities feature cardiothoracic, complex spinal, and neurosurgery, as well as neonatal intensive care. Tenet extends its offerings to ultra-specialized quaternary care, exemplified by heart and kidney transplant programs, and sophisticated procedures such as limb-salvaging vascular interventions, acute Level 1 trauma care, intravascular stroke treatment, minimally invasive cardiac valve replacements, advanced imaging, and telemedicine access. Beyond its hospital network, Tenet manages numerous other clinical sites. These encompass outpatient surgical centers, immediate care facilities, diagnostic imaging centers, dedicated surgical hospitals, off-campus emergency departments, and micro-hospitals. Through its Conifer segment, the company furnishes critical healthcare business process solutions. These administrative services, offered to hospitals, health systems, physician practices, employers, and other clients, include financial administration for patient accounts (revenue cycle management), support for patient communications and engagement, and outcome-focused care strategies. As of February 9, 2022, Tenet's operational footprint included 60 hospitals and roughly 550 additional medical facilities. This count of additional sites comprises surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and various other clinical locations. Tenet Healthcare Corporation was established in 1975 and maintains its principal office in Dallas, Texas.
THC Stock 12 Month Forecast
Average Price Target
$241.29
▲(22.70% Upside)
Technical Analysis
Ownership Overview
0.97% Insiders
29.53% Mutual Funds
0.61% Other Institutional Investors
43.37% Public Companies and Individual Investors









